PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160116480A1
SERIAL NO

14890933

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of evaluating the sensitivity or resistance of a cancer cell to an antitumoral therapeutic treatment. It further relates to the treatment of a cancer with an inhibitor of the eiF4F complex used for the sensitisation of said cancer to an antitumoral therapeutic treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE101 RUE DE TOLBIAC PARIS 75013
UNIVERSITY PARIS-SACLAYBÂTIMENT BREGUET 3 RUE JOLIOT CURIE GIF SUR YVETTE 91190

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOUSSEMART, LISE PARIS, FR 2 0
GIRAULT, ISABELLE VILLEJUIF, FR 3 0
ROBERT, CAROLINE FONTENAY-AUX-ROSES, FR 17 139
VAGNER, STÉPHAN VERRIERES LE BUISSON, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation